Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
September 28, 2020
Psychosocial and productivity impact of caring for a child with peanut allergy
Sarah Acaster, Katy Gallop, Jane de Vries, et al.
Patient Preference and Adherence
|
May 27, 2022
Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers
Katy Gallop, Sarah Acaster, Jane de Vries, et al.
Journal of Women'S Health (2002)
|
June 14, 2011
Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study
Ron Falcon, Dawn Averitt Bridge, Judith Currier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 10, 2016
Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women
Moti Ramgopal, Olayemi Osiyemi, Carmen Zorrilla, et al.
Plos One
|
December 3, 2020
A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergy
Vibha Sharma, Jennifer Jobrack, Wendy Cerenzia, et al.
AIDS Research and Treatment
|
April 27, 2012
Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial
Thomas Kakuda, Vanitha Sekar, Peter Vis, et al.
AIDS Patient Care and Stds
|
May 25, 2013
Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey
Kathleen Squires, Judith Feinberg, Dawn Averitt Bridge, et al.
Journal of the National Medical Association
|
October 25, 2012
Assessing darunavir/ritonavir-based therapy in a racially diverse population: 48-week outcomes from GRACE
Kimberly Y Smith, Fernando Garcia, Princy Kumar, et al.
AIDS Patient Care and Stds
|
May 27, 2011
Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks
Judith S Currier, Claudia Martorell, Olayemi Osiyemi, et al.
Antiviral Therapy
|
August 17, 2010
Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults
Edwin DeJesus, Jacob P Lalezari, Olayemi O Osiyemi, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
September 28, 2020
Psychosocial and productivity impact of caring for a child with peanut allergy
Sarah Acaster, Katy Gallop, Jane de Vries, et al.
Patient Preference and Adherence
|
May 27, 2022
Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of Health State Utility Values for Children and Adolescents and Their Caregivers
Katy Gallop, Sarah Acaster, Jane de Vries, et al.
Journal of Women'S Health (2002)
|
June 14, 2011
Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study
Ron Falcon, Dawn Averitt Bridge, Judith Currier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 10, 2016
Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women
Moti Ramgopal, Olayemi Osiyemi, Carmen Zorrilla, et al.
Plos One
|
December 3, 2020
A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergy
Vibha Sharma, Jennifer Jobrack, Wendy Cerenzia, et al.
AIDS Research and Treatment
|
April 27, 2012
Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial
Thomas Kakuda, Vanitha Sekar, Peter Vis, et al.
AIDS Patient Care and Stds
|
May 25, 2013
Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey
Kathleen Squires, Judith Feinberg, Dawn Averitt Bridge, et al.
Journal of the National Medical Association
|
October 25, 2012
Assessing darunavir/ritonavir-based therapy in a racially diverse population: 48-week outcomes from GRACE
Kimberly Y Smith, Fernando Garcia, Princy Kumar, et al.
AIDS Patient Care and Stds
|
May 27, 2011
Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks
Judith S Currier, Claudia Martorell, Olayemi Osiyemi, et al.
Antiviral Therapy
|
August 17, 2010
Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults
Edwin DeJesus, Jacob P Lalezari, Olayemi O Osiyemi, et al.
Page
of 8